oleanolic acid has been researched along with Cardiovascular Diseases in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 15 (93.75) | 24.3611 |
2020's | 1 (6.25) | 2.80 |
Authors | Studies |
---|---|
Chen, WH; Chen, X; Hou, N; Li, D; Lu, YJ; Sun, N; Wong, WL; Wu, P | 1 |
Jiang, H; Sun, A | 1 |
Ferriol, P; Monserrat-Mesquida, M; Pinya, S; Sureda, A; Tejada, S | 1 |
Kim, BM | 1 |
Gamede, M; Khathi, A; Mabuza, L; Ngubane, P | 1 |
Akizawa, T; Audhya, P; Bakris, GL; Chertow, GM; Christ-Schmidt, H; de Zeeuw, D; Goldsberry, A; Krauth, M; Lambers Heerspink, HJ; Linde, P; McMurray, JJ; Meyer, CJ; Parving, HH; Remuzzi, G; Toto, RD; Vaziri, ND; Wanner, C; Wittes, J; Wrolstad, D | 1 |
Himmelfarb, J; Tuttle, KR | 2 |
Akizawa, T; Audhya, P; Bakris, GL; Chertow, GM; Chin, M; Christ-Schmidt, H; de Zeeuw, D; Goldsberry, A; Houser, M; Krauth, M; Lambers Heerspink, HJ; McMurray, JJ; Meyer, CJ; Parving, HH; Remuzzi, G; Toto, RD; Vaziri, ND; Wanner, C; Wittes, J; Wrolstad, D | 1 |
Chertow, GM; de Zeeuw, D | 1 |
Chartoumpekis, DV; Sykiotis, GP | 1 |
Kovács, T; Molnár, GA; Wittmann, I | 1 |
Ellison, DH | 1 |
Van Biesen, W; Van Laecke, S; Vanholder, R | 1 |
de Zeeuw, D; Meyer, C | 1 |
Rodriguez-Rodriguez, R | 1 |
4 review(s) available for oleanolic acid and Cardiovascular Diseases
Article | Year |
---|---|
New Applications of Oleanolic Acid and its Derivatives as Cardioprotective Agents: A Review of their Therapeutic Perspectives.
Topics: Cardiotonic Agents; Cardiovascular Diseases; Humans; Oleanolic Acid | 2019 |
Hypotensive Effects of the Triterpene Oleanolic Acid for Cardiovascular Prevention.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Oleanolic Acid; Triterpenes | 2021 |
The Role of Saikosaponins in Therapeutic Strategies for Age-Related Diseases.
Topics: Apoptosis; Cardiovascular Diseases; Cell Cycle Checkpoints; Humans; Liver Diseases; Neoplasms; Neurodegenerative Diseases; Obesity; Oleanolic Acid; Oxidative Stress; Saponins | 2018 |
Oleanolic acid and related triterpenoids from olives on vascular function: molecular mechanisms and therapeutic perspectives.
Topics: Animals; Cardiovascular Diseases; Humans; Molecular Conformation; Olea; Oleanolic Acid; Triterpenes | 2015 |
2 trial(s) available for oleanolic acid and Cardiovascular Diseases
Article | Year |
---|---|
Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial.
Topics: Adolescent; Adult; Aged; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Oleanolic Acid; Prognosis; Renal Insufficiency, Chronic; Young Adult | 2013 |
Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.
Topics: Aged; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; NF-E2-Related Factor 2; Oleanolic Acid; Renal Insufficiency, Chronic; Treatment Failure; Weight Loss | 2013 |
10 other study(ies) available for oleanolic acid and Cardiovascular Diseases
Article | Year |
---|---|
Novel Findings and Therapeutic Targets in Cardioprotection.
Topics: Aging; Cardiotonic Agents; Cardiovascular Diseases; Cardiovascular System; Humans; Myocardial Infarction; Oleanolic Acid | 2019 |
Plant-Derived Oleanolic Acid (OA) Ameliorates Risk Factors of Cardiovascular Diseases in a Diet-Induced Pre-Diabetic Rat Model: Effects on Selected Cardiovascular Risk Factors.
Topics: Animals; Biomarkers; Blood Glucose; Cardiovascular Diseases; Cytokines; Diabetes Mellitus, Experimental; Diet, High-Fat; Disease Models, Animal; Fasting; Inflammation Mediators; Oleanolic Acid; Oxidative Stress; Plant Extracts; Prediabetic State; Rats; Risk Factors | 2019 |
New therapies for diabetic kidney disease.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Oleanolic Acid; Renal Insufficiency, Chronic | 2013 |
Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Oleanolic Acid; Renal Insufficiency, Chronic | 2014 |
Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Oleanolic Acid; Renal Insufficiency, Chronic | 2014 |
Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Oleanolic Acid; Renal Insufficiency, Chronic | 2014 |
Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Oleanolic Acid; Renal Insufficiency, Chronic | 2014 |
Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Oleanolic Acid; Renal Insufficiency, Chronic | 2014 |
The paradox of bardoxolone methyl: a call for every witness on the stand?
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Oleanolic Acid; Renal Insufficiency, Chronic | 2015 |
The paradox created by commenting on large clinical trial results.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Oleanolic Acid; Renal Insufficiency, Chronic | 2015 |